Serine‐227 in the N‐terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphoma. - Matsumura‐Kimoto, Yayoi; Tsukamoto, Taku; Shimura, Yuji; Chinen, Yoshiaki; Tanba, Kazuna; Kuwahara‐Ota, Saeko; Fujibayashi, Yuto; Nishiyama, Daichi; Isa, Reiko; Yamaguchi, Junko; Kawaji‐Kanayama, Yuka; Kobayashi, Tsutomu; et al. (Cancer Medicine, 2020)